Starting next month, Yahoo Japan will begin selling a disease-focused genetic testing kit directly to consumers. For 29,800 yen, around $370, customers can order the GeneLife2012 test kit, which will search for genetic variants associated with the risk of developing diseases such as diabetes, stroke, and heart disease, according to a press release.
Customers will ship off some spit for analysis, which will be handled by another Tokyo-based company, Genesis Health Care. The company will look for disease-assocated changes in 68 genes.
According to the Japan Times, Yahoo Japan will play only a marketing role and will not handle any data from the medical tests. But, if I am interpreting Google Translation’s interpretation of the press release correctly, it seems the Tokyo-based Internet giant is looking to expand its role as a source for health-care information and potentially its presence in the growing trend for individuals to monitor their own health. The company says the GeneLife2012 test will help prevent or slow diseases by alerting customers to the need for lifestyle changes through diet, exercise, and stress management.
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.
Data analytics reveal real business value
Sophisticated analytics tools mine insights from data, optimizing operational processes across the enterprise.
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.